CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 937162-937375 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T20433","span":{"begin":0,"end":213},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"We suggest that retargeting of lesion distribution by antibody could be a potentially clinically important and previously unappreciated element of antibody action in MS and, as such, require further investigation."}

{"project":"Epistemic_Statements","denotations":[{"id":"T2049","span":{"begin":0,"end":213},"obj":"Epistemic_statement"}],"text":"We suggest that retargeting of lesion distribution by antibody could be a potentially clinically important and previously unappreciated element of antibody action in MS and, as such, require further investigation."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T339","span":{"begin":0,"end":213},"obj":"Sentence"}],"text":"We suggest that retargeting of lesion distribution by antibody could be a potentially clinically important and previously unappreciated element of antibody action in MS and, as such, require further investigation."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T3907","span":{"begin":166,"end":168},"obj":"Body_part"}],"attributes":[{"id":"A3907","pred":"uberon_id","subj":"T3907","obj":"http://purl.obolibrary.org/obo/UBERON_0001877"}],"text":"We suggest that retargeting of lesion distribution by antibody could be a potentially clinically important and previously unappreciated element of antibody action in MS and, as such, require further investigation."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T5892","span":{"begin":166,"end":168},"obj":"Disease"},{"id":"T84712","span":{"begin":166,"end":168},"obj":"Disease"}],"attributes":[{"id":"A5892","pred":"mondo_id","subj":"T5892","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"},{"id":"A55352","pred":"mondo_id","subj":"T84712","obj":"http://purl.obolibrary.org/obo/MONDO_0005301"}],"text":"We suggest that retargeting of lesion distribution by antibody could be a potentially clinically important and previously unappreciated element of antibody action in MS and, as such, require further investigation."}